first glp-1 approval Navigating the -tides: Medication-Assisted Weight Loss on the Forefront First Oral GLP-1 WEIGHT LOSS

1 Introduction Methotrexate (MTX) is a dihydrofolate reductase inhibitor and chemotherapeutic agent with proven efficiency against cancers and rheumatoid arthritis (Kozminski et al., 2020)

As weight-loss drugs reduce appetites, US restaurants cut portion sizes Some New York restaurants are offering smaller portions at lower prices to appeal to those on hunger-reducing GLP-1 weight-loss medications A foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has loved exploring the citys famed restaurant culture for a long time

According to Table 1, comprehensive experimental and observational studies reveal that GLP-1RAs do not elevate overall cancer risk, while preclinical investigations have demonstrated multiple anti-tumor mechanisms, including proliferation inhibition, apoptosis induction, and metastasis suppression

GLP-1 medications can cause nausea, vomiting, and diarrhea, all of which contribute to fluid loss